Placebo and nocebo effects are defined by opposite opioid and dopaminergic responses.
about
Catechol-O-methyltransferase val158met polymorphism predicts placebo effect in irritable bowel syndromeDistinct brain systems mediate the effects of nociceptive input and self-regulation on painMolecular neurobiology of addiction: what’s all the (Δ)FosB about?Neuroimaging of the periaqueductal gray: state of the fieldNeurobiological mechanisms of placebo responsesPain-related effects of trait anger expression: neural substrates and the role of endogenous opioid mechanismsThe Neurobiology Shaping Affective Touch: Expectation, Motivation, and Meaning in the Multisensory ContextApplication of cross-species PET imaging to assess neurotransmitter release in brainA Trigger for Opioid Misuse: Chronic Pain and Stress Dysregulate the Mesolimbic Pathway and Kappa Opioid SystemMedicine and psychiatry in Western culture: Ancient Greek myths and modern prejudicesHypnotizability and Placebo Analgesia in Waking and Hypnosis as Modulators of Auditory Startle Responses in Healthy Women: An ERP StudyThe relation of emotions to placebo responses.Acute pain and a motivational pathway in adult rats: influence of early life pain experiencePlacebo improves pleasure and pain through opposite modulation of sensory processing.Pain, decisions, and actions: a motivational perspective.Imaging opioid analgesia in the human brain and its potential relevance for understanding opioid use in chronic pain.Placebo Analgesia Changes Alpha Oscillations Induced by Tonic Muscle Pain: EEG Frequency Analysis Including Data during Pain Evaluation.Neuroimaging study of placebo analgesia in humans.Biological, clinical, and ethical advances of placebo effects.Open-label versus double-blind placebo treatment in irritable bowel syndrome: study protocol for a randomized controlled trial.Separating analgesia from reward within the ventral tegmental area.Understanding gut-brain interactions in gastrointestinal pain by neuroimaging: lessons from somatic pain studies.Qualitative study of Nocebo Phenomenon (NP) involved in doctor-patient communicationReduced Pain Sensation and Reduced BOLD Signal in Parietofrontal Networks during Religious Prayer.Neurobiology of placebo effects: expectations or learning?A key role of the basal ganglia in pain and analgesia--insights gained through human functional imagingBuilding up analgesia in humans via the endogenous μ-opioid system by combining placebo and active tDCS: a preliminary reportPlacebo analgesia and reward processing: integrating genetics, personality, and intrinsic brain activityExpectancy and treatment interactions: a dissociation between acupuncture analgesia and expectancy evoked placebo analgesiaBlack cohosh has central opioid activity in postmenopausal women: evidence from naloxone blockade and positron emission tomography neuroimagingA new transient sham TENS device allows for investigator blinding while delivering a true placebo treatment.Individual expectation: an overlooked, but pertinent, factor in the treatment of individuals experiencing musculoskeletal pain.How placebos change the patient's brain.Role of μ-opioid system in the formation of memory of placebo responses.Nocebo is the enemy, not placebo. A meta-analysis of reported side effects after placebo treatment in headaches.Sex similarities and differences in pain-related periaqueductal gray connectivity.Brain mediators of predictive cue effects on perceived pain.Placebo and other psychological interactions in headache treatment.Prediction of placebo responses: a systematic review of the literature.Effects of amphetamine on the human brain opioid system--a positron emission tomography study.
P2860
Q21133920-A8D7C689-E2AB-4800-AC1C-B88B06E7E556Q21145701-F5F4707B-C6F9-4D9A-B5A4-97EEFF311F82Q22241263-E1E01CB0-B518-400A-B19B-0FF0C7588DE6Q24289416-2279D2D0-7E85-4AC8-AE70-037D3AF2B525Q24621444-59E56A65-E362-4DAC-B834-80B986FCCB85Q24658054-96BD3362-B9BB-4AA1-AE67-5F6854FBF76CQ26771487-7EC8DFF9-B43F-4EED-9E03-2124148E6EB7Q26865012-FE85EDC7-E6A5-4E84-9CF2-3EB5CB403A52Q28074686-5E7FA57C-FC4F-4F52-8D76-A6F4DDF6DAAAQ28750488-7F0DA32A-FF49-4967-AC22-439CB8C68E82Q30376312-DB277BE6-CBCB-492A-B8CD-9AFDAE4B2994Q30466387-E46272C1-3B1C-4789-B216-A379E4D2D234Q30468904-DA2B1B33-89FE-411A-B4F5-B0CB0F70A103Q30556706-ED936D49-B0E6-40CF-9384-3CA51F3D3707Q30613170-5EC72401-18D4-4301-9A7B-C5BC6F311300Q30657653-022E501C-25C8-45F1-8783-561FD87F0077Q31104169-980DAFCA-28E1-4E02-A75D-B0C118526B76Q33506955-22573F18-4FCE-443B-A5E8-94EFC75358A2Q33703954-37EEFA37-5130-4CA5-84BD-FECD7A5ED4F8Q33730499-A3F88820-FA9B-43A1-B85C-74FF192F99B2Q33791677-820E6424-FEC1-4EC6-9F06-34CFC9817479Q33799784-18D40487-0DEB-41F3-BAFC-345C61AB03F0Q33821347-0CD3F183-4736-4263-AAB5-BD76CB382B60Q33843330-E05F0152-FF32-453C-8101-5AA697C52EF8Q33878264-A0EE711C-6CFB-4121-BEB2-F525C814621BQ33907230-A49F4E53-5B4C-45CB-B032-62069320DA54Q33910791-70D75976-A4F5-47C5-ABCC-4B05F28154B4Q33934473-D367F1FF-7989-4546-B65A-557EDB262B1CQ34015718-2677E0BF-E80B-4C50-A711-677D387A0926Q34042073-35F554A8-9124-43AC-8542-A454E93C1379Q34067773-193E6483-E8AB-49AB-83D6-BD2D75E4A1BFQ34098568-16D5A80C-CE69-499E-BDDE-FF463F1FAA72Q34123529-54B9CF5C-E117-4018-9F97-833E5370E00DQ34124922-D6CF16B1-DC33-4E93-B413-815DDBC9C52EQ34158126-34890F5F-B25A-435B-B320-C7106E5BD1FFQ34239382-82D632FE-024D-460E-9EF1-113F2E58287DQ34253395-7FBB2D03-D6E2-429A-89B0-045A71C641ACQ34257107-9D6E8FAE-15A0-402C-AEBE-ABFE809E45B5Q34272476-C6258E28-69BE-4E89-8938-C8AB5D65882AQ34296653-0314C379-5E24-4B7C-B044-0110063A918B
P2860
Placebo and nocebo effects are defined by opposite opioid and dopaminergic responses.
description
2008 nî lūn-bûn
@nan
2008 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Placebo and nocebo effects are defined by opposite opioid and dopaminergic responses.
@ast
Placebo and nocebo effects are defined by opposite opioid and dopaminergic responses.
@en
Placebo and nocebo effects are defined by opposite opioid and dopaminergic responses.
@nl
type
label
Placebo and nocebo effects are defined by opposite opioid and dopaminergic responses.
@ast
Placebo and nocebo effects are defined by opposite opioid and dopaminergic responses.
@en
Placebo and nocebo effects are defined by opposite opioid and dopaminergic responses.
@nl
prefLabel
Placebo and nocebo effects are defined by opposite opioid and dopaminergic responses.
@ast
Placebo and nocebo effects are defined by opposite opioid and dopaminergic responses.
@en
Placebo and nocebo effects are defined by opposite opioid and dopaminergic responses.
@nl
P2093
P921
P1433
P1476
Placebo and nocebo effects are defined by opposite opioid and dopaminergic responses.
@en
P2093
Christian S Stohler
Christine M Egnatuk
David J Scott
Jon-Kar Zubieta
Robert A Koeppe
P304
P356
10.1001/ARCHGENPSYCHIATRY.2007.34
P407
P577
2008-02-01T00:00:00Z